Oceania Cruises has announced La Table par Maîtres Cuisiniers de France, an exclusive new fine dining restaurant set to debut aboard the Oceania Sonata in 2027. This restaurant, endorsed by the Maîtres Cuisiniers de France, will be the first and only one at sea to receive such prestigious approval, welcoming just 18 guests for a refined, reservation-only experience. The menu, created by Master Chefs of France Alexis Quaretti and Eric Barale, will showcase exquisite French culinary artistry, further solidifying Oceania Cruises' commitment to culinary excellence.

SueWallSt is encouraging investors who suffered losses in Boston Scientific Corporation (NYSE: BSX) to join a securities fraud class action lawsuit. The lawsuit alleges that Boston Scientific misrepresented its electrophysiology (EP) procedure growth between July 23, 2025, and February 3, 2026, leading to a significant stock drop when the slower-than-expected growth and increased competition were disclosed. Investors who purchased BSX securities during this period may be eligible to recover damages.

Prologis (PLD) saw its stock rise after reporting first-quarter earnings that surpassed analyst estimates. The industrial REIT also increased its 2026 guidance to above consensus figures. The company achieved record lease signings of 64 million square feet in its logistics portfolio.

Morgan Stanley initiated coverage on Verizon Communications Inc. (NYSE:VZ) with an Equalweight rating and a price target of $49.00. Analysts anticipate that Verizon, currently trading below its fair value, will improve its market share by focusing on customer experience and reducing churn, moving away from relying solely on promotions. The firm projects significant improvements in postpaid phone net adds and adjusted EBITDA growth for 2026, driven by operational efficiencies and a workforce reduction.

Institutional investor Lbp Am Sa has significantly increased its stake in Amgen Inc. (NASDAQ:AMGN) by 108.1% in the 4th quarter, now owning 51,776 shares valued at $16.9 million. This suggests Lbp Am Sa's strong confidence in Amgen's future performance and growth prospects as a major player in the pharmaceutical industry. The increase in institutional investment highlights Wall Street's belief in Amgen's long-term potential in developing innovative biologic medicines.

Nations Financial Group Inc. IA ADV has increased its stake in Quanta Services, Inc. (NYSE:PWR) by 41.9%, acquiring an additional 2,598 shares to own a total of 8,803 shares valued at approximately $3.716 million. Quanta Services reported strong quarterly earnings, beating analyst estimates, and has received a "Moderate Buy" consensus rating from Wall Street analysts with an average price target of $595.50. The company also declared a quarterly dividend of $0.11 per share.

Caesars Entertainment has secured a multi-year licensing deal with MLB Players, Inc., allowing Caesars Sportsbook and William Hill Nevada to use MLB player imagery in their marketing efforts. This agreement aims to enhance fan engagement by featuring actual players in their mobile apps and retail locations. The new MLB season began on March 25, and Caesars Entertainment Inc. (NASDAQ:CZR) shares saw a gain following the news.

Waton Financial (NASDAQ: WTF) celebrates its first anniversary as a listed company by introducing MOTA (Manager of Trading Agents), a platform designed for human-AI investment collaboration. Unlike other AI trading tools, MOTA focuses on regulated infrastructure, embedded compliance, and human oversight, emphasizing that AI suggests while humans decide. The company positions MOTA to address the missing conversation around licensing and accountability in the AI trading industry, aligning with evolving global AI regulations.

Starbucks recently integrated ordering capabilities within ChatGPT, allowing users to select coffee based on mood before being redirected to the app to complete the purchase. This strategy addresses income statement pressures by leveraging AI to reduce operational costs through its "Green Apron Assistant" and improve customer acquisition efficiency. While the stock has seen modest gains, its future performance hinges on the AI initiatives effectively impacting profitability and customer acquisition amidst challenges like technical costs, data integration complexities, and the sustainability of AI-driven advantages.

Xilio Therapeutics (Nasdaq: XLO) has appointed Cheryl R. Blanchard, Ph.D., a biotech veteran with over 30 years of experience, to its board of directors, effective April 16, 2026. Dr. Blanchard's expertise in biologics, devices, and commercial strategy, including her current role as executive chair of Anika, is expected to support Xilio's masked immuno-oncology pipeline. This appointment follows the departure of Christina Rossi from the board on April 15, 2026.